[Therapy of acute nonlymphocytic leukemia: 2. Biological characteristics and prediction of response].
D000208:Acute Disease; D000367:Age Factors; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007239:Infections / Q000150:complications; D007938:Leukemia / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism
D003561:Cytarabine; D004317:Doxorubicin; D003630:Daunorubicin